A practical reference on LC-MS/MS: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-05-18 and is reviewed periodically as new material appears.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
| Property | Value | Notes |
|---|---|---|
| Primary research area | Obesity and metabolic regulation | Studied in cell, animal, and human models |
| Highest reported trial phase | Phase II | Public summaries describe mixed results |
| Common route in trials | Subcutaneous injection | Typical for peptide therapeutics |
| Regulatory example | 2013 Australian anti-doping review | Classification was debated at the time |
| Approval status | Not approved as a human medicine | Status can change by jurisdiction |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
== Further reading == papuamide Ford, PW; Gustafson, KR; McKee, TC; Shigematsu, N; Maurizi, LK; Pannell, LK; Williams, DE; de Silva, ED; Lassota, P; Allen, TM; Van Soest, R; Andersen, RJ; Boyd, MR (1999). "Papuamides A-D, HIV-Inhibitory and Cytotoxic Depsipeptides from the Sponges Theonella mirabilis and Theonella swinhoei Collected in Papua New Guinea". J. Am. Chem. Soc. 121 (25): 5899–5909. Bibcode:1999JAChS.121.5899F. doi:10.1021/ja990582o. neamphamide A Oku, N; Gustafson, KR; Cartner, LK; Wilson, JA; Shigematsu, N; Hess, S; Pannell, LK; Boyd, MR; McMahon, JB (2004). "Neamphamide A. A new HIV-inhibitory depsipeptide from the Papua New Guinea marine sponge Neamphius huxleyi". J. Nat. Prod. 67 (8): 1407–11. Bibcode:2004JNAtP..67.1407O. doi:10.1021/np040003f. PMID 15332865. callipeltin A Zampella, A; D'Auria, MV; Paloma, LG; Casapullo, A; Minale, L; Debitus, C; Henin, Y (1996). "Callipeltin A, an Anti-HIV Cyclic Depsipeptide from the New Caledonian Lithistida Sponge Callipelta sp.". J. Am. Chem. Soc. 118 (26): 6202–9. Bibcode:1996JAChS.118.6202Z. doi:10.1021/ja954287p. mirabamides A-D Plaza, A; Gustchina, E; Baker, HL; Kelly, M; Bewley, CA (2007). "Mirabamides A-D. Depsipeptides from the sponge Siliquariaspongia mirabilis that inhibit HIV-1 fusion". J. Nat. Prod. 70 (11): 1753–60. Bibcode:2007JNAtP..70.1753P. doi:10.1021/np070306k. PMID 17963357.; Andjelic, CD; Planelles, V; Barrows, LR (2008). "Characterizing the Anti-HIV Activity of Papuamide A." Mar Drugs. 6 (4): 528–49. doi:10.3390/md20080027. PMC 2630844. PMID 19172193.
== Clinical significance == Studies on the obestatin/ghrelin ratio in the gastrointestinal tract and plasma are associated with some diseases such as irritable bowel syndrome (IBS), obesity, Prader–Willi syndrome, and type II diabetes mellitus.
Ceftriaxone and other third-generation cephalosporin antibiotics are used to treat organisms that tend to be resistant to many other antibiotics. Due to emergent resistance, ceftriaxone should not be used for the treatment of Enterobacter infections. Before using ceftriaxone, it is important to determine the susceptibility of the bacteria. If sepsis is being considered, empiric therapy may be initiated prior to susceptibility testing. Medical uses include:
== Science == Colorants function through selective electromagnetic absorbance in the visible spectrum. A given pigment or dye molecule absorbs different wavelengths of electromagnetic radiation according to its atomic structure and local chemical environment. The quantum behavior of a chemical typically results in distinct resonant frequencies of chemical bonds, which can be excited best by discrete wavelengths—meaning broad spectrum radiation has its spectra changed via absorption upon interaction. The physical shape, size, organization, and concentration of dyes and pigments can also drastically affect observed color. Pigments are particularly susceptible to altered appearances based on physical properties. Most modern synthetic dye molecules contain two components. The first part is an aromatic benzene ring or system of benzene rings, often substituted. The second is a chromophore, a conjugated double bond system with unsaturated groups. When exposed to visible light, this part absorbs or reflects color. Other components of colorant molecules can tune intensity, color, solubility and substrate affinity. Dyes and pigments can be categorized according to their synthetic or chemical properties. British chemist Edward Chambers Nicholson showed that pure aniline produced no dye. Hofmann showed that toluidine must be present to make these dyes. Aniline dyes, including mauve, are prepared from aniline-containing amounts of toluidine. One can also classify dyes based on chemical formulas, azo-dyes from coupling, or diazonation—reactions with a characteristic azo group.
Glucagon receptor Glucagon-like peptide 1 receptor Glucagon-like peptide 2 receptor Gastric inhibitory polypeptide receptor The first three receptors bind closely related peptide hormones (glucagon, glucagon-like peptide-1, glucagon-like peptide-2) derived from the proglucagon polypeptide. The last receptor binds gastric inhibitory polypeptide.
Sources: en.wikipedia.org
== Politics == Christian Heritage Party (disambiguation) Christian Historical Party (1903–1908), a Dutch conservative party Republican People's Party (Cumhuriyet Halk Partisi), a Turkish centre-left party
In March 2025, Cerebras announced plans to construct six new datacenters in Dallas, Minneapolis, Oklahoma City, Montreal, New York, and France, increasing inference capacity twentyfold to over 40 million tokens per second, expecting increased demand from Llama 4 and DeepSeek. Meta Platforms agreed to use Cerebras products to power the Llama API in April 2025. In April 2025, Cerebras and Ranovus announced a contract from DARPA. In May 2025, Cerebras beat NVIDIA's Blackwell in Llama 4 Inference with more than 2,500 tokens per second/user, compared to 1,000 for Blackwell, on the 400B-parameter Llama 4 Maverick model in testing by an independent benchmarking firm. In July 2025, Cerebras unveiled Qwen3-235B, an ultra-fast deployment of Alibaba Group's open-weight Qwen AI models, with full 131k context support on its inference cloud platform. In January 2026, Cerebras signed a deal with OpenAI to deliver 750 megawatts of computing power through 2028 for $10 billion. As part of the agreement with OpenAI, the company is temporarily prohibited from selling its products to Anthropic. In March 2026, Amazon Web Services agreed to purchase CS-3 systems to be used for its Trainium-powered servers set to be deployed on Amazon Bedrock in its data centers. In August 2026, CS-4 system was introduced.
King Crimson have been described musically as progressive rock, art rock, and post-progressive, with their earlier works being described as proto-prog. Their music was initially grounded in the rock of the 1960s, especially the acid rock and psychedelic rock movements. The band played Donovan's "Get Thy Bearings" in concert, and were known to play the Beatles' "Lucy in the Sky with Diamonds" in their rehearsals. However, for their own compositions, King Crimson (unlike the rock bands that had come before them) largely stripped away the blues-based foundations of rock music and replaced them with influences derived from classical composers. The first incarnation of King Crimson played the Mars section of Gustav Holst's suite The Planets live and later the band used Mars as a foundation for the song "Devil's Triangle". As a result of this influence, In the Court of the Crimson King is frequently viewed as the nominal starting point of the progressive rock movements. King Crimson also initially displayed strong jazz influences, especially on its signature track "21st Century Schizoid Man". The band also drew on English folk music for compositions such as "Moonchild" and "I Talk to the Wind". In the 1972 lineup, Fripp's intention was to combine the music of Jimi Hendrix, Igor Stravinsky and Béla Bartók. The 1981 reunion of the band brought in even more elements, displaying the influence of funk, post-punk, new wave, gamelan music and minimalist classical composers such as Philip Glass, Steve Reich and Terry Riley.
=== French Mandate === After the fall of the Ottoman Empire in 1918, the Syrian National Congress was convened in May 1919 in Damascus. In September 1920, Henri Gouraud, High Commissioner of the Levant, formed a representative council, with two-thirds elected and one-third appointed by the French administration. On 28 June 1922, the Syrian Federation was established, creating a Federation Council of 15 members from various states. Due to the lack of elections, these members were appointed by the High Commissioner in 1923, and their terms were extended the following year. In 1925, after the formation of the State of Syria, President Ahmad Nami and High Commissioner Henri Ponsot agreed to hold elections for a constituent assembly to draft a constitution. This led to the first Syrian legislative elections in 1928, which elected 68 representatives but was later disbanded on 5 February 1929. Article 30 of the 1930 Syrian constitution established a legislative authority known as the Chamber of Deputies, with representatives elected for four-year terms. The first elections for the Chamber of Deputies were held in December 1931 and January 1932. The first council met in June 1932 and facilitated a compromise that led to Muhammad Ali Bey al-Abid's presidency. In the 1936 elections, the National Bloc won the majority of seats in the Chamber, and Hashim al-Atassi was elected president. Concurrently, negotiations with France led to the independence treaty, ratified by the Chamber of Deputies in December 1936.
Sources: en.wikipedia.org
Historically, snuff spoons were used for cocaine in the 20th century, hence the names "cocaine spoon" and "coke spoon". Some local statutes in the US treat spoons that are too small and thus "unsuited for the typical, lawful uses of a spoon" as drug paraphernalia.
As a consequence, the editosome can edit only in a 3' to 5' direction along the primary RNA transcript. The complex can act on only a single guide RNA at a time. Therefore, a RNA transcript requiring extensive editing will need more than one guide RNA and editosome complex.
== Side effects == Side effects of doxylamine include dizziness, drowsiness, and dry mouth, among others. Doxylamine is a potent anticholinergic and has a side-effect profile common to such drugs, including blurred vision, dry mouth, constipation, muscle incoordination, urinary retention, mental confusion, and delirium. Because of its relatively long elimination half-life (10–12 hours), doxylamine is associated with next-day effects including sedation, drowsiness, grogginess, dry mouth, and tiredness when used as a hypnotic. This next-day sedation may be described as a "hangover effect". The shorter elimination half-life of diphenhydramine (4–8 hours) compared to doxylamine may give it an advantage over doxylamine as a sleep aid in this regard. Antihistamines like doxylamine are sedating initially but tolerance occurs with repeated use and can result in rebound insomnia upon discontinuation. Occasional case reports of coma and rhabdomyolysis have been reported with doxylamine overdose. This pattern is in contrast to diphenhydramine. Studies of doxylamine's carcinogenicity in mice and rats have produced positive results for both liver and thyroid cancer, especially in the mouse. The carcinogenicity of the drug in humans is not well-studied, and the International Agency for Research on Cancer lists the drug as "not classifiable as to its carcinogenicity to humans". Continuous and/or cumulative use of anticholinergic medications, including first-generation antihistamines, is associated with a higher risk of cognitive decline and dementia in older people.
=== Television === Coatsworth is Nine Network's Medical Expert appearing regularly as a guest on Nine Network programmes. He is presenter of a Nine Network television show he created, Do You Want To Live Forever? which he hosts with Tracey Grimshaw. He has been a guest on multiple television programs including:
1787–1797: Self-taught Chinese astronomer Wang Zhenyi published at least twelve books and multiple articles on astronomy and mathematics. Using a lamp, a mirror and a table, she once created a famous scientific exhibit designed to accurately simulate a lunar eclipse. 1786–1797: German astronomer Caroline Herschel discovered eight new comets, along with numerous other discoveries. 1789: French astronomer Louise du Pierry, the first Parisian woman to become an astronomy professor, taught the first astronomy courses specifically open to female students. 1794: British chemist Elizabeth Fulhame invented the concept of catalysis and published a book on her findings. c. 1796–1820: During the reign of the Jiaqing Emperor, astronomer Huang Lü became the first Chinese woman to work with optics and photographic images. She developed a telescope that could take simple photographic images using photosensitive paper. 1797: English science writer and schoolmistress Margaret Bryan published A Compendious System of Astronomy, including an engraving of herself and her two daughters. She dedicated the book to her students.
Sources: en.wikipedia.org
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.
It became prominent during a 2013 Australian sports investigation that examined whether it was a prohibited growth-hormone-related substance. Subsequent interpretations and list updates have varied, so current rules should be checked directly.
Published summaries generally report limited or inconsistent weight-loss effects, and complete trial data are not widely available. The studies were not sufficient to establish it as an effective obesity treatment.
Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.